← Browse by Condition
Medical Condition
polycystic ovary syndrome
Total Trials
8
Recruiting Now
8
Trial Phases
EARLY_Phase 1, Phase 1, Phase 2, Phase 2
ClinicalMetric tracks all active clinical trials for polycystic ovary syndrome sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — polycystic ovary syndrome Clinical Trials
How many clinical trials are currently recruiting for polycystic ovary syndrome?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for polycystic ovary syndrome, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for polycystic ovary syndrome?
polycystic ovary syndrome research spans Phase 1 (3 trials), Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a polycystic ovary syndrome clinical trial?
Eligibility criteria for polycystic ovary syndrome trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 3
Phase 2 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT04723862 EARLY_Phase 1
Recruiting
Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?
Enrollment
32 pts
Location
United States
Sponsor
University of Virginia
NCT05706922
Recruiting
Gut- and Vaginal Microbiome Composition in Association With PCOS
Enrollment
200 pts
Location
Netherlands
Sponsor
Erasmus Medical Center
NCT06519656 Phase 1, Phase 2
Recruiting
Efficacy of Mazdutide for Treating PCOS
Enrollment
50 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
NCT06545721
Recruiting
Weight Cycling on Hyperandrogenemia and Insulin Resistance in Polycystic Ovary Syndrome
Enrollment
425 pts
Location
China
Sponsor
Peking Union Medical College H...
NCT05950282
Recruiting
Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
Enrollment
150 pts
Location
United States
Sponsor
Ali Chappell
NCT02647827 Phase 2
Recruiting
Acupuncture or Metformin for Insulin Resistance in Women With PCOS
Enrollment
303 pts
Location
China, Sweden
Sponsor
Karolinska Institutet
NCT07446985
Recruiting
Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma?
Enrollment
40 pts
Location
Egypt
Sponsor
Cairo University
NCT07403201 EARLY_Phase 1
Recruiting
The Effect of Therapy Combination in PCOS With Dlbs 3233
Enrollment
90 pts
Location
Indonesia
Sponsor
Inlacinpenelitian
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology